Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Manufacture and Sale of Cosmetics	519.97M	526.01M	729.61M	594.26M	430.50M
Manufacture and Sale of Cosmetics Growth	-1.15%	-27.91%	22.78%	38.04%	-
Total	519.97M	526.01M	729.61M	594.26M	430.50M
Total Growth	-1.15%	-27.91%	22.78%	38.04%	-

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Egypt	485.30M	510.98M	699.15M	587.43M
Egypt Growth	-5.03%	-26.91%	19.02%	-
Export	34.67M	15.02M	30.46M	6.83M
Export Growth	130.77%	-50.68%	345.91%	-
Total	519.97M	526.01M	729.61M	594.26M
Total Growth	-1.15%	-27.91%	22.78%	-

Source: S&P Global Market Intelligence.